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Abstract 24 
 25 
The present study aimed to analyse the autonomic nervous system activity using heart 26 
rate variability (HRV) to detect sleep disordered breathing (SDB) patients with and 27 
without excessive daytime sleepiness (EDS) before sleep onset. 28 
 29 
Two groups of 20 patients with different levels of daytime sleepiness -sleepy group, 30 
SG; alert group, AG- were selected consecutively from a Maintenance of Wakefulness 31 
Test (MWT) and Multiple Sleep Latency Test (MSLT) research protocol. The first 32 
waking 3-min window of RR signal at the beginning of each nap test was considered for 33 
the analysis. HRV was measured with traditional linear measures and with time-34 
frequency representations. Non-linear measures -correntropy, CORR; auto-mutual-35 
information function, AMIF- were used to describe the regularity of the RR rhythm. 36 
Statistical analysis was performed with non-parametric tests.  37 
 38 
Non-linear dynamic of the RR rhythm was more regular in the SG than in the AG 39 
during the first wakefulness period of MSLT, but not during MWT. AMIF (in high-40 
frequency and in Total band) and CORR (in Total band) yielded sensitivity > 70%, 41 
specificity >75% and an area under ROC curve > 0.80 in classifying SG and AG 42 
patients. 43 
 44 
The regularity of the RR rhythm measured at the beginning of the MSLT could be used 45 
to detect SDB patients with and without EDS before the appearance of sleep onset. 46 
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Introduction 47 
 48 
Sleep-disordered breathing (SDB) is a common disorder with a range of harmful 49 
sequelae [1]. One of the most important symptoms is excessive daytime sleepiness 50 
(EDS) which has been related to an increase of driving accidents, psychosocial 51 
morbidity and poor quality of life [2-4]. Despite its relevance in clinical management, 52 
evaluation of EDS is hindered by the lack of a simple objective method.  53 
Subjective sleepiness scales are easy to fill out but correlate poorly with objective 54 
measures [5, 6] because patients sometimes are unaware of their sleepiness or it is 55 
confounded with fatigue or depression [7]. In contrast, the multiple sleep latency test 56 
(MSLT) [8] and the maintenance of wakefulness test (MWT) [9] which are accepted as 57 
the gold standards to objectively assess EDS, are relatively complex and expensive to 58 
perform on daily routine. Thus, there is a pressing need to develop simplified objective 59 
methods that could be used broadly in clinical and real-life scenarios. 60 
 61 
Recent studies suggest that changes in the level of sleepiness are associated with   62 
changes in autonomic nervous system (ANS) activity [10,11]. For instance, somnolent 63 
SDB patients have an abnormal sympatho-vagal balance during sleep [11] and an 64 
increased sympathetic tone during daytime wakefulness that normalizes after 65 
continuous positive airway pressure (CPAP) treatment [12]. This suggests that the 66 
structural alterations and dysfunction in central autonomic regulatory regions occurring 67 
in SDB might contribute to EDS [13].  68 
 69 
In this context, ANS activity could be a potential candidate to measure EDS in SDB.   70 
The simplest way to monitor ANS activity is by measuring the heart rate variability 71 
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(HRV), which describes fluctuations in autonomic inputs to the heart over time. It is 72 
measured by the variation in the beat-to-beat (RR) interval in the electrocardiogram 73 
(EKG) [14]. Different methods have quantified HRV. From the traditional linear 74 
measures to the more sophisticated time-frequency representation and non-linear 75 
techniques.  76 
 77 
Mean heart rate (HR), a simple time-domain measure, gradually decreases as sleep 78 
begins and achieves its lower value when stable N2 sleep stage appears [15-18]. In 79 
preadolescents a significant decreasing in heart rate even occurs as earlier as 30 seconds 80 
before the appearance of stage N1 [15]. It has also been described that subjects with 81 
longer sleep latencies in the MSLT and MWT present an increased HR at the beginning 82 
of each test [19-21]. Moreover, using some frequency-domain measures, Bonnet et 83 
Arand also found an increased sympatho-vagal balance in the non-sleepy subjects, 84 
without changes in the parasympathetic nervous system activity [22]. These findings in 85 
healthy adults suggest that measurements of ANS activity during wakefulness periods 86 
could help to study the EDS associated to SDB. 87 
 88 
Non-linear methods have been developed recently to describe non-linear fluctuations in 89 
heart rate and inform about the regularity of heart rate time series [23]. It has been 90 
reported that non-linear dynamics of EEG signal during the first wakefulness period at 91 
the beginning of the MSLT is more regular (i.e. lower complexity) in SDB patients with 92 
objective EDS than in those without EDS [24]. However, little is known about the non-93 
linear dynamics of cardiac activity related to EDS.      94 
 95 
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Using HRV measures, we aimed to find possible markers of ANS activity that could 96 
anticipate sleep onset in SDB patients and, therefore, detect patients with and without 97 
objective EDS. We analysed the first 3-min waking periods of the MWT and the MSLT 98 
to perform the study.   99 
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Materials and methods 100 
 101 
Subjects 102 
From a series of 98 consecutive patients with suspected SDB evaluated at the 103 
Multidisciplinary Sleep Disorders Unit of the Hospital Clinic of Barcelona, two groups 104 
of 20 consecutive patients each were selected, based on mean sleep latencies from a 105 
MWT-MSLT research protocol. The sleepy group (SG) consisted of the most somnolent 106 
patients who have both low MSLT (< 8 min) and low MWT (< 20 min)sleep latencies 107 
while the alert group (AG) represented the least somnolent patients with the higher 108 
MWT (≥ 20 min) and MSLT (≥ 8 min ) sleep latencies. Patients with discordance 109 
between MWT and MSLT scores (patients with MWT ≥ 20 min and MSLT < 8 min or 110 
MWT < 20 min and MSLT ≥ 8 min) were considered partially sleepy and were not 111 
included in the analysis. Exclusion criteria were age under 18 years, major medical or 112 
psychiatric disorders, use of beta-blockers or medications affecting wakefulness or 113 
sleep, and working in shifts or with irregular sleep-wake schedules during the four 114 
weeks before the sleep study. Nocturnal polisomnography (PSG) excluded any 115 
concomitant sleep disorder other than SDB.  116 
 117 
The study was approved by the Hospital Clinic of Barcelona ethics committee (Comité 118 
Ètic Investigació Clínica (CEIC)) and written informed consent was obtained from all 119 
participants. 120 
 121 
 122 
 123 
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Design 124 
Patients arrived to the sleep lab at 6 pm and underwent a 24-hour sleep study. 125 
Subjective daytime sleepiness and mood disorders were assessed using the Epworth 126 
Sleepiness Scale and the Hospital Anxiety and Depression Scale.  After nocturnal PSG, 127 
a MWT-MSLT research protocol was conducted to quantify EDS throughout the day. 128 
An overview of the protocol is shown in Table 1. 129 
 130 
 131 
Nocturnal PSG was performed according to standard practice parameters and diagnostic 132 
criteria [25, 26]. We recorded EEG (O2-A1, O1-A2, C4-A1, C3-A2, F4-A1, F3-O2), 133 
electrooculography, EKG, chin and right and left anterior tibialis surface 134 
electromyography, and synchronized audiovisual recording. Cannula, thermistor, 135 
abdominal and thoracic strain gauges, and finger pulse oximeter were used to measure 136 
respiratory variables. Apnea was defined as a complete cessation of airflow, measured 137 
using thermistor, for ≥ 10 sec. Hypopnea was defined as ≥ 30% reduction in nasal 138 
pressure signal excursions from baseline and associated ≥ 3% desaturation from pre-139 
event baseline or an arousal. The apnea-hypopnea index (AHI) was the number of 140 
apneas plus hypopneas per hour of sleep. Sleep stages were manually scored according 141 
to Rechtschaffen and Kales criteria using 30-s epochs. 142 
 143 
MSLT and MWT protocol 144 
Patients underwent 5 trials of MWT followed by a research version MSLT [8, 27], 145 
every two hours starting at 8:30 am. We recorded in total 200 MSLT and 200 MWT 146 
naps. The order in which the tests took place was the same for all subjects. Between 147 
naps, patients were allowed to leave their rooms and stay in the waiting area, 148 
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performing routine activities or interacting with other patients in a quiet way. They were 149 
advised to avoid sleep between naps and technicians ensured this. Caffeine beverages 150 
were not allowed. 151 
 152 
For the MWT, patients were seated at 45º, and were instructed to “remain awake for as 153 
long as possible”. For the MSLT, patients were instructed to “lie quietly in a 154 
comfortable position and try to fall asleep”. Test conditions, light intensity and 155 
temperature followed the standard recommendations from AASM 2005 [28]. Additional 156 
EKG was recorded using a 2-channel bipolar monitoring system with one electrode 157 
placed 2 cm below the right clavicle and the other 2 cm below the left clavicle.  158 
 159 
If no sleep occurred MWT and MSLT trials were ended after 40 and 20 minutes 160 
respectively, or after unequivocal sleep, defined as three consecutive epochs of stage 1 161 
sleep, or one epoch of any other stage of sleep. Objective daytime sleepiness was 162 
measured from sleep latency defined as time from lights out to the first epoch of 163 
unequivocal sleep in each test.  164 
 165 
Assessment of Heart Rate Variability  166 
The RR series, intervals between consecutive beats, were obtained from each EKG nap 167 
recording with a sampling frequency of 256 Hz. After removing artifacts and ectopic 168 
beats, RR signals were resampled at 4 Hz. Naps with sleep latencies shorter than two 169 
minutes or EKG artifacts could not be analysed and were excluded. Then, the first 170 
waking 3-min window of RR signal at the beginning of each nap test was considered for 171 
the analysis whenever possible; otherwise we decided to fix a minimum window size of 172 
2-min.  173 
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Heart rate variability was described by measures obtained from traditional time-domain 174 
analysis (mean and standard deviation of RR interval), power spectral analysis in 175 
frequency-domain (individual low frequency and high frequency spectral power and 176 
low frequency to high frequency spectral powers ratio) [14] and Time-Frequency 177 
Representations (TFR) based on Choi-Williams Distribution [29]. Non-linear measures 178 
- correntropy (CORR) and auto-mutual-information function (AMIF) - were used to 179 
describe the regularity of the RR signal since they are suitable to be constructed based 180 
on short-term series [30, 31]. The applied methodology, the parameters involved in the 181 
calculation of TFR, CORR and AMIF are shown in the Supporting Information File. 182 
All these measures were calculated in the following frequency bands: low frequency 183 
(LF: 0.04-0.15 Hz), high frequency (HF: 0.15-0.4 Hz) and total band (TB: total 184 
frequency band). The analysis in the very low frequency band (<0.04 Hz) was not 185 
performed because 5-min of RR signal is the minimal window recommended for this 186 
purpose [14]. 187 
 188 
Since the present study was carried out analyzing only one short-length window of RR 189 
for each nap, the stationarity does not represent a significant problem [14]. A final 190 
check by visual inspection was carried out in order to ensure the analysis of artifact-free 191 
RR epochs.  192 
 193 
Data and statistical analysis 194 
Mean values of HRV measures of all MWT and all MSLT naps for each patient were 195 
considered for the analysis.  They could be calculated if at least 3 MSLT and 3 MWT 196 
naps had available data.  197 
 198 
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Heart rate variability measures were compared between AG and SG using Mann-199 
Whitney U test and within each group (between the MWT and the MSLT) with 200 
Wilcoxon signed-rank test. Bonferroni correction was applied and a significance level 201 
p-value < 0.004 was taken into account. Those HRV parameters that significantly 202 
differed between groups were evaluated throughout the day to confirm the results 203 
obtained in the average analysis. Associations between HRV measures and mean sleep 204 
latencies were evaluated with Spearman rank-order test, with a statistical significance 205 
assumed for p < 0.05. 206 
 207 
A discriminant function was built with those HRV parameters that significantly differed 208 
between groups. The leaving-one-out method was performed as a validation method. 209 
Sensitivity (Sen) and specificity (Spe) were calculated for testing the performance of the 210 
measures. The proportion of SG patients correctly classified was counted by Sen and the 211 
proportion of AG patients correctly classified by Spe. The area under the ROC curve 212 
(AUC) was also used to test the performance of the measures. The ROC curve was 213 
computed for the results of the predictions calculated with a logistic regression 214 
classification using a generalized linear model. The model was built by fitting a 215 
generalized linear regression of the predicted classes on the measures, using a normal 216 
distribution [32]. 217 
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Results  218 
Patient’s characteristics and PSG results are shown in Table 2. Most patients were male 219 
and overweight. The SG was slightly younger and tended to have more subjective 220 
complaints of daytime sleepiness in comparison to the AG. All subjects slept well, with 221 
mean sleep efficiency higher than 80% and more than 6 h of sleep. Sleep structure was 222 
similar in both groups, but the longer stage 2 sleep latency in the AG. There was a wide 223 
spectrum of disease severity in both groups but the mean AHI and the associated 224 
oxygen desaturation index tended to be higher in the SG than in the AG, without 225 
achieving statistical significance. As expected by selection criteria, SG had shorter sleep 226 
latencies than the AG:  MWT (11.5 ± 4.54 min versus 35.3 ± 6.33 min, p-value< 0.001) 227 
and MSLT (4.4 ± 1.96 min versus 11.66 ± 2.41 min, p-value< 0.001). 228 
 229 
Of the 400 naps recorded, thirty naps (7.5%) had sleep latencies shorter than 2 minutes 230 
or had EKG artefacts that did not allow interpreting the RR signal. Three subjects from 231 
the SG did not have the minimal HRV measures required (at least 3 MSLTs and 3 232 
MWTs naps with available data) and were excluded from the analysis. Regarding the 233 
window size of the RR signal, 344 from the remaining 370 available naps (93%) were 234 
analysed using three minutes and in the other 26 out naps with latencies between 2 and 235 
3 minutes the window size equalled the length of sleep latency.  236 
 237 
Differences between groups occurred exclusively during the MSLT (Table 3). We 238 
found that AMIF (in Total and HF band) and CORR (in Total Band) showed a more 239 
regular RR rhythm in the SG than in the AG (p < 0.004, after Bonferroni correction). 240 
This behaviour was confirmed in each of 5 MSLT naps throughout the day (p < 0.004 241 
after Bonferroni correction). During the MWT, the RR rhythm was similar in both 242 
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groups. Differences between nap tests mainly occurred in the SG, showing a more 243 
regular RR rhythm during MSLT than during MWT in AMIF (in all frequency bands, p-244 
range <0.001 – 0.002) and CORR (in Total band, p<0.001). In the AG, no differences 245 
were observed between MWT and MSLT except for the AMIF in HF band, which 246 
showed an increased regularity of the RR rhythm during the MSLT (p < 0.001). Figure 247 
1(A) shows the evolution of AMIF in HF band in both groups throughout the whole nap 248 
protocol. 249 
 250 
No differences between groups were observed in any traditional linear and TFR 251 
measures, either in MSLT or MWT. However, we found that mean RR interval was 252 
longer (i.e. slower heart rate) during the MSLT than during the MWT, independently of 253 
the sleepiness group: the SG (985.2 ± 149.6 ms and 937.9 ± 138.2 ms, p < 0.001) and 254 
the AG (964.4 ± 94.9 ms and 921.3 ± 97.3 ms, p < 0.001). Figure 1(B) shows the 255 
evolution of mean RR interval in both groups throughout the nap protocol. 256 
 257 
Correlation analysis showed that patients with shorter MSLT sleep latency had higher 258 
regularity of the RR rhythm. The best correlations were found with AMIF in HF band 259 
(rho -0.49, p-value = 0.002) and AMIF in Total band (rho -0.47, p-value = 0.003), 260 
followed by CORR in Total band (rho -0.41, p-value = 0.01) (Figure 2).  261 
 262 
Each of the three measures yielded a Sen ≥ 70%, Spe > 75% and AUC > 0.80 263 
discriminating the AG from the SG. However, AMIF in Total and HF bands achieved 264 
slightly better results than CORR in Total band (see Table 4).  265 
 266 
  267 
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Discussion 268 
 269 
To our knowledge, this is the first study that uses linear and non-linear measures applied 270 
to RR signal in order to detect SDB patients with and without objective EDS. Using this 271 
approach we have demonstrated that the regularity of the RR rhythm during the first 3-272 
min of wakefulness at the MSLT allows differentiating the sleepy from the alert 273 
patients. In contrast, in a situation where sleep latencies were much longer as occurs 274 
during the MWT, non-linear dynamics did not differ between groups. 275 
 276 
We have observed that both AMIF (in HF and Total band) and CORR (in Total band) 277 
functions showed an increased regularity of the RR rhythm in sleepy patients, in 278 
comparison to alert patients during the first wakefulness period at the beginning of the 279 
MSLT. In a previous study, Melia U et Al. evaluated the regularity (conversely, the 280 
complexity) of the EEG signal using CORR functions and found that sleepy patients 281 
had a more regular EEG signal (analyzed in the β band) in the occipital region than alert 282 
patients also during the same nap test [24]. The findings obtained with the analysis of 283 
RR interval go in the same direction than those from the EEG, suggesting a common 284 
mechanism. We hypothesize that the increased regularity observed in the SG during the 285 
first waking 3-min could reflect the autonomic changes occurring with the proximity of 286 
sleep onset. The SG had shorter sleep latencies than the AG (4.4 ± 1.96 minutes versus 287 
11.66 ± 2.41 minutes, respectively) and, therefore, even at the beginning of the test they 288 
were much closer to the EEG sleep onset than the AG. We confirmed these association 289 
with the correlation analysis showing that the RR signal was more regular when MSLT 290 
sleep latency was shorter (i.e. when sleep onset was closer). The lack of differences 291 
between groups at the MWT may also support our hypothesis. During this test, patients 292 
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are instructed to remain awake and sleep latencies are expected to be longer, as we 293 
observed in our study (MWT sleep latencies were longer than 10 minutes in both 294 
groups). However, we cannot exclude other factors that characterize MWT, such as the 295 
body position, the open eyes or the environmental dim-light that could have conditioned 296 
our results during this test.  297 
 298 
We failed to observe differences between groups in traditional linear and TFR 299 
measures. Our results contrast with a study performed in healthy young adults that 300 
showed an increased heart rate and a higher sympatho-vagal balance in the alert subjects 301 
during MSLT (MSLT sleep latency < 7min), compared to the sleepy subjects (MSLT 302 
sleep latency < 7min) [22]. However, the sample, subject‘s age, nap protocol and 303 
window size of our work differ from that study and may have influenced the results. In 304 
another study performed in SDB patients with and without EDS during nocturnal sleep, 305 
Lombardi et al. [11] showed that the sleepy group had an increased cardiac sympatho-306 
vagal balance (low frequency to high frequency spectral power ratio) throughout the 307 
whole night. We assumed that during wakefulness, confounding factors that may 308 
influence the cardiac rhythm such as sleep-related respiratory events are not to be 309 
expected. However, we cannot discard that breathing instability typical of the transition 310 
from wakefulness to sleep may have occurred in some patients during the measurement 311 
of HRV and, therefore, conditioned the results. Another work by Donadio et al. [13], 312 
who evaluated the muscle sympathetic nerve activity by microneurography, determined 313 
that severity of EDS in sleepy SDB patients was related to daytime sympathetic 314 
hyperactivity. In our study, we failed to find similar results due in part to the different 315 
protocols and techniques used to measure ANS activity, since Donadio et al. had not an 316 
alert SDB group to compare with.  317 
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 318 
Despite the mean RR internal was unable to differentiate between the AG and SG, it 319 
varied between MSLT and MWT regardless the level of sleepiness. The mean RR 320 
interval was reliably shorter (i.e. heart rate was faster) during the MWT, without 321 
associated changes in other traditional linear measures. It has been argued that the 322 
differences between tests are related to changes in physiological level of arousal. In fact, 323 
specific methodological conditions distinguish each test, promoting to remain awake in 324 
MWT and to fall asleep in MSLT. From this point of view, the effect of upright tilt-up 325 
[33, 34] and its combination with the instruction to remain awake could explain  the 326 
increase in heart rate, accompanying the longer sleep latencies typically observed during 327 
the MWT [21]. We have also corroborated the influence of the time of day on heart rate, 328 
with special emphasis during the digestion in the 4th block of MSLT/MWT [21]. At that 329 
moment, heart rate was almost identical for MSLT and MWT in both groups and 330 
achieved its highest values of all day (i.e. lowest RR interval) (see Figure 1(B)). 331 
 332 
This study has several inherent limitations. First, we could not analyze HRV with the 333 
recommended 5-min windows of RR signal because of the nature of our investigation 334 
[14]. The SG, which was characterized by very short periods of wakefulness before the 335 
appearance of sleep onset, showed sleep latencies shorter than 5 minutes in 65 of 100 336 
MSLT naps that prevented the calculation of mean HRV values in this group and the 337 
comparison with the AG. The selection of window size of 3-min increased the number 338 
of available naps to evaluate HRV but, again, the most somnolent patients did not show 339 
enough RR signal in 40 of 100 MSLT naps. Therefore, we decided to find a 340 
compromise between the window length analyzed and the number of naps excluded 341 
from the analysis. To maximize the number of available MSLT naps in the SG, we 342 
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included those naps with sleep latencies between 2 and 3 minutes and we evaluated 343 
HRV with a window size that equaled the length of sleep latency. In this way, we could 344 
get more information about the HRV associated to sleepiness in the SG and thus, to 345 
calculate the mean HRV values and compare the groups. A second limitation is that we 346 
did not monitor breathing during naps and thus, we cannot exclude the inclusion of 347 
occasional windows containing sleep-related respiratory events that could have 348 
influenced our results. This cannot be, however, a major problem because the MWT and 349 
MSLT protocols that we used were ended as soon as the patients fall asleep. Finally, 350 
care must be taken with the discrimination ability of the AMIF and CORR functions to 351 
identify each group, considering the small number of subjects and the lack of validation 352 
set.  353 
 354 
There is a clear need for a simple and practical tool that could be routinely administered 355 
during wakefulness to diagnose those individuals with EDS and to prevent the 356 
undesirable consequences related to EDS. In the clinical practice, MSLT is considered 357 
the reference test for objectively measure daytime sleepiness and is mainly based on 358 
EEG. However, it requires more than 10 electrodes correctly placed on the scalp and 359 
face and a trained technician to interpret the signals. In our study, we have evaluated 360 
EDS with a simpler an easier to record signal than EEG. Two EKG derivations and a 3-361 
min window of waking RR signal recorded at the beginning of MSLT were enough to 362 
detect significant differences in regularity of cardiac rhythm between the AG and the 363 
SG. De Gennaro et al. have also measured the oculomotor activity (another easy to 364 
record biological signal) during the first waking 150-sec from MSLT and found that a 365 
decrease in spontaneous blinking and an increase in slow eye movements were 366 
associated with shorter sleep latencies [35] These two works reflect the potential 367 
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applicability of alternative biological signals to EEG for monitoring sleepiness in the 368 
clinical practice and diagnose EDS. Furthermore, the reliable detection of drowsiness in 369 
real-life scenarios such as driving has received increased interest in the last few decades, 370 
mainly for the purpose of preventing driving accidents and errors [36]. Although several 371 
automatic detection methods exist, those that employ biological signal processing are 372 
the most feasible because they inform about the body’s response to drowsiness. Some 373 
high-risk professions such as professional drivers could benefit from these automatic 374 
detectors of sleepiness for preventing accidents at the wheel. We propose that the 375 
development of new EKG indexes based on AMIF and correntropy functions may allow 376 
the automatic detection of sleepiness in this setting. However, we are still far and further 377 
studies should be addressed. 378 
 379 
 380 
In conclusion, non-linear dynamics of the RR rhythm may detect those SDB patients 381 
with and without EDS before the appearance of MSLT sleep onset. Larger studies 382 
including different degrees of daytime sleepiness, and different window sizes of RR 383 
signal analysis would be of interest to elucidate the importance of non-linear measures 384 
of HRV in the identification of EDS while the subject is awake. The evaluation along 385 
the entire wake-sleep transition during sleep latency tests and also during other 386 
scenarios (i.e. driving simulations) should also be tested to elucidate if the findings 387 
observed at the beginning of the test would remain stable or changed as sleep onset 388 
approaches. 389 
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Figure Legends 486 
 487 
Figure 1. Representation of (A) AMIF-HF and (B) mean RR interval throughout 488 
the 5 blocks of MWT and MSLT.  489 
Sleepy group, in blue, alert group, in red.  In graphic (A), SG shows an increased 490 
regularity of RR rhythm during almost all nap tests in comparison to AG, especially at 491 
the MSLT. Within each group, however, there is a type of nap test effect, with increased 492 
values at the MSLT in comparison to MWT.  In graphic (B), both groups show a 493 
reliably longer mean RR interval (i.e. slower heart rate) during MSLT as compared to 494 
MWT, but there are no differences between groups in any test. The lowest values of all 495 
naps are seen during the 1st and 4th block, after breakfast and lunch time. Abbreviations: 496 
SG, sleepy group; AG, alert group; AMIF-HF, Auto-mutual information function in 497 
high frequency band; mean RR, mean RR interval; MWT, maintenance of wakefulness 498 
test; MSLT, multiple sleep latency test.  499 
 500 
 501 
Figure 2. Correlation between (A) AMIF-TB, (B)  AMIF-HF, and (C) CORR-TB 502 
with sleep latency from MSLT of all subjects, when using averages. 503 
In blue the SG, in red the AG. Regression lines are represented in black. Note that 504 
patients with shorter sleep latencies showed an increased regularity of the RR rhythm 505 
(rho in: (A) -0.47, (B) -0.49, (C) -0.41, p < 0.05). Abbreviations: Auto-mutual 506 
information function (AMIF) in: total band (AMIF-TB), high-frequency band (AMIF-507 
HF); Correntropy function in total band (CORR-TB); MSLT, Multiple Sleep Latency 508 
Test.  509 
 510 
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Tables 511 
Table 1. Sleep Study Design 
  
18:00 Enter to Sleep Lab
18:30 ESS, HAD 
19:00 Electrodes placement
20:00 Dinner 
23:00 Start PSG 
7:30 End PSG 
7:30 – 8:15 Breakfast 
8:30 – 9:10 1st  MWT  
9:30 – 9:50  1st  MSLT 
10:30 – 11:10 2nd MWT  
11:30 – 11:50  2nd MSLT 
12:30 – 13:10 3rd MWT  
13:30 – 13:50  3rd MSLT 
13:50 – 14:15 Lunch 
14:30 – 15:10  4th MWT 
15:30 – 15:50 4th MSLT 
16:30 – 17:10  5th MWT 
17:30 – 17:50  5th MSLT 
 
 
ESS, Epworth Sleepiness Scale; HAD, Hospital 
Anxiety and Depression Scale PSG, Polysomnography; 
MWT, Maintenance of Wakefulness Test; MSLT, 
Multiple Sleep Latency Test. 
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Table 2. Clinical and PSG characteristics: descriptive data and differences between groups. 
 SLEEPY GROUP ALERT GROUP p-values 
CLINICAL VARIABLES    
Sex (Male/Female) 14/6 14/6 NS 
Age (years old) 53.4 ± 6.0 57.5 ± 7.8 *0.04 
Body Mass Index (kg/ m2) 29,9 ± 4,5 29,2 ± 4.8 NS (0.48) 
Epworth Sleepiness Scale 12.8 ± 3.9 10.9 ± 4.6 NS (0.09) 
HADS-A 5.9 ± 2.8 4.9 ± 3.0 NS (0.24) 
HADS-D 4,4 ± 3,3 2,9 ± 2.9 NS (0.09) 
SLEEP QUALITY    
Time in Bed (min) 463.6 ± 29.0 468.0± 28.5 NS (0.75) 
Total Sleep Time (min) 381,2 ± 75,7 372,5 ± 48.8 NS (0.34) 
Sleep Efficiency (%) 81,1 ± 14,6 79,8 ± 8.9 NS (0.15) 
Wake After Sleep Onset (min) 70,8 ± 54,2 69,5 ± 34.1 NS (0.36) 
SLEEP STRUCTURE    
Stage 2 sleep latency (min) 18,0 ± 23,3 25,2 ± 19.9 *0.01 
REM sleep latency (min) 132,1 ± 83,9 102,7 ± 67.3 NS (0.32) 
Stage 1 (%) 17.7 ± 10.6 17.4 ± 9.0 NS (0.98) 
Stage 2 (%) 59,3 ± 8,7 56,8 ± 9.2 NS (0.81) 
Stage 3 (%) 8.4 ± 6.7 11.4 ± 7.9 NS (0.28) 
REM sleep (%) 14.7 ± 6.8 14.4 ± 6.0 NS (0.86) 
Number of REM episodes 3,6 ± 1,6 3,7 ± 1.5 NS (0.99) 
Number of Phase Changes 181.5 ± 68.5 171.8 ± 58.3 NS (0.83) 
PLM Index (events/h) 9,0 ± 22,8 6,2 ± 11.8 NS (0.98) 
RESPIRATORY PARAMETERS    
Arousal Index (events/h) 39,7 ± 22,9 32,4 ± 21.1 NS (0.21) 
Apnea-Hypopnea Index (events/h) 40,1 ± 28,0 27,7 ± 26.9 NS (0.06) 
Mean SaO2 (%) 93,3 ± 2,1 93,2 ± 3.0 NS (0.61) 
Cumulative time spend below a SaO2 of 90% 10,5 ± 13,5 9,7 ± 16.7 NS (0.19) 
Oxigen desaturation Index 3% 31,1 ± 25,0 22,0 ± 29.0 NS (0.08) 
Nadir of Sa O2 77,8 ± 8,9 81,2 ± 12.0 NS (0.18) 
With the exception of sex proportion all results are expressed as mean ± SD. Level of significance was for p <  0.05. NS, non-
significant. 
Abbreviations: HADS-A, hospital anxiety and depression scale – Anxiety; HADS-D, hospital anxiety and depression scale – 
Depression; PLM Index, periodic limb movements index; Sa O2, oxygen desaturation. 
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Table 3. Linear, Time-Frequency Representation and Nonlinear measures at the beginning of MSLT and MWT: descriptive data and 
differences between groups. 
 MSLT  MWT 
 SG AG p SG AG p 
LINEAR  MEASURES       
MeanRRi (ms) 985,23 ± 149,61 964,39 ± 94,85 NS (0,915) 937,90 ± 138,16 921,32 ± 97,26 NS (0,796) 
STDRRi (ms) 47,22 ± 18,69 36,29 ± 10,16 NS (0,091) 40,91 ± 18,52 38,56 ± 10,61 NS (0,819) 
LF (a.u) 58,25 ± 11,85 56,98 ± 7,35 NS (0,532) 56,71 ± 10,00 57,56 ± 8,58 NS (0,915) 
HF (a.u) 41,75 ± 11,85 43,02 ± 7,35 NS (0,532) 43,29 ± 10,00 42,44 ± 8,58 NS (0,915) 
LF/HF ratio (a.u) 1,87 ± 0,88 1,73 ± 0,73 NS (0,615) 1,65 ± 0,71 1,82 ± 0,65 NS (0,410) 
TFR MEASURES       
TFR-TB ( ms2) 4582,56 ± 3914,34 2624,44 ± 1398,56 NS (0,156) 4417,47 ± 4366,42 3126,50 ± 2300,46 NS (0,522) 
TFR-LF (a.u) 1,75E-05 ± 7,22E-06 1,48E-05 ± 2,82E-06 NS (0,532) 1,52E-05 ± 3,49E-06 1,36E-05 ± 2,69E-06 NS (0,120) 
TFR-HF (a.u) 8,29E-06 ± 4,97E-06 5,79E-06 ± 1,76E-06 NS (0,065) 5,35E-06 ± 1,71E-06 4,90E-06 ± 1,99E-06 NS (0,353) 
NON-LINEAR MEASURES       
AMIF-TB (a.u) 0,39 ± 0,04 0,35 ± 0,03 0,001* 0,36 ± 0,04 0,35 ± 0,02 NS (0,855) 
AMIF-LF (a.u) 0,48 ± 0,04 0,44 ± 0,03 NS (0,004) 0,46 ± 0,04 0,45 ± 0,03 NS (0,474) 
AMIF-HF (a.u) 0,34 ± 0,04 0,32 ± 0,02 0,001* 0,32 ± 0,02 0,30 ± 0,02 NS (0,075) 
CORR-TB (a.u) 0,36 ± 0,05 0,31 ± 0,04 0,001* 0,30 ± 0,04 0,31 ± 0,07 NS (0,749) 
CORR-LF (a.u) 0,28 ± 0,05 0,27 ± 0,03 NS (0,419) 0,25 ± 0,04 0,26 ± 0,04 NS (0,512) 
CORR-HF (a.u) 0,36 ± 0,09 0,33 ± 0,05 NS (0,532) 0,34 ± 0,06 0,32 ± 0,06 NS (0,139) 
Results are expressed as mean ± SD. After Bonferroni correction, level of significance was *: p< 0.004. NS, non-significant.  
Abbreviations: MSLT, multiple sleep latency test; MWT, maintenance of wakefulness test; meanRRi, mean RR interval; SDVRRi, standard deviation of the RR 
interval; LF(nu), low-frequency spectral power; HF(nu) high-frequency spectral power; LF/HF ratio, low-frequency to high-frequency spectral power ratio; TFR 
measures, Time-frequency representation  in: total band (TFR-TB), low-frequency band (TFR-LF), high-frequency band (TFR-HF); Auto-mutual information 
function (AMIF) in: total band (AMIF-TB), low-frequency band (AMIF-LF), high-frequency band (AMIF-HF); Correntropy (CORR) in: total band (CORR-TB); 
low-frequency band (CORR-LF); high-frequency band. Units of measurement: ms, milliseconds; a.u, absolute units; ms2, square milliseconds. 
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Table 4. Discrimination between the AG and SG at the MSLT.  
 Sen (%) Spe (%) AUC 
AMIF-TB 71 80 0,83 
AMIF-HF 76 85 0,81 
CORR-TB 71 75 0,81 
Abbreviations: Sen, sensibility; Spe, specificity, AUC, area under the 
curve; Auto-mutual information function (AMIF) in: total band (AMIF-
TB), ) and high-frequency band (AMIF-HF);  Correntropy in total band 
(CORR-TB). 
